Derivation and Internal Validation of the GLaSSES Score for Predicting Neurological Deterioration after Acute Ischemic Stroke: A Retrospective Cohort Study
Journal of Cerebrovascular Sciences · 2026-01 · 14 (1) · 10-17
DOI: 10.4103/jcvs.jcvs_5_26 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Journal of Cerebrovascular Sciences, online erschienen am 31.07.2026. Verfasst von Mauricio Emanuel De Sampaio und 5 weiteren Autor:innen. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Schlaganfall
Abstract (Originalsprache)
A BSTRACT Background and Purpose: Neurological deterioration (ND) occurs in 5%–40% of patients with acute ischaemic stroke (AIS) during the 1 st week and is associated with worse outcomes and increased mortality. We aimed to develop and internally validate a simple bedside score for predicting ND in AIS patients not receiving reperfusion therapy.
Methods
We conducted a retrospective cohort study including adults hospitalised with AIS between May 2021 and December 2023. ND within 7 days was recorded. A multivariable logistic regression model was developed using stepwise selection based on the Akaike Information Criterion. Internal validation was performed with 1000 bootstrap resamples. Calibration was assessed using the Hosmer–Lemeshow test and calibration plots. The optimal cut-off was determined using the Youden index.
Results
A total of 444 patients were included, and 90 (20.3%) developed ND. Five independent predictors were identified: admission hyperglycaemia, leucocytosis, National Institutes of Health Stroke Scale severity, symptomatic intracranial stenosis and symptomatic extracranial stenosis. The derived GLaSSES score showed good discrimination and calibration. The Hosmer–Lemeshow test showed no significant lack of fit ( P = 0.1008). A cut-off of 17.5 points yielded a sensitivity of 75.6%, specificity of 90.1%, positive predictive value of 66.0% and negative predictive value of 93.5%. Mortality was higher among patients with ND (47.8%).
Conclusions
The GLaSSES score is a simple bedside tool for predicting ND after AIS. External validation is required before clinical implementation.
Zitieren
APA
Sampaio, M. E. D., Carra, M. A., Putalivo, J. A. P., Fonzo, G. D., Grecco, M. P., & Povedano, G. P. (2026). Derivation and Internal Validation of the GLaSSES Score for Predicting Neurological Deterioration after Acute Ischemic Stroke: A Retrospective Cohort Study. Journal of Cerebrovascular Sciences, 14(1), 10-17. https://doi.org/10.4103/jcvs.jcvs_5_26
Vancouver
Sampaio MED, Carra MA, Putalivo JAP, Fonzo GD, Grecco MP, Povedano GP. Derivation and Internal Validation of the GLaSSES Score for Predicting Neurological Deterioration after Acute Ischemic Stroke: A Retrospective Cohort Study. Journal of Cerebrovascular Sciences. 2026;14(1):10-17. doi:10.4103/jcvs.jcvs_5_26
BibTeX
@article{Sampaio2026,
author = {Sampaio, Mauricio Emanuel De and Carra, María Agostina and Putalivo, Juan Antonio Pozo and Fonzo, Guido Di and Grecco, Martín Pablo and Povedano, Guillermo Pablo},
title = {Derivation and Internal Validation of the GLaSSES Score for Predicting Neurological Deterioration after Acute Ischemic Stroke: A Retrospective Cohort Study},
journal = {Journal of Cerebrovascular Sciences},
year = {2026},
volume = {14},
number = {1},
pages = {10--17},
doi = {10.4103/jcvs.jcvs_5_26}
}
EUVIMED